Victrelis
Merck and Roche extend Victrelis co-promotion deal to Europe
July 22, 2011Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C
Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
Hep C drug Victrelis gains EU approval
July 20, 2011Sales and Marketing Incivek, Victrelis, hepatitis C
Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
Hepatitis C rivals go head to head
July 19, 2011Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
NICE to appraise hep C drugs Victrelis and telaprevir
May 26, 2011Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir
NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
CHMP roundup
May 24, 2011Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy
The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …
Merck’s hepatitis drug Victrelis approved by FDA
May 16, 2011Sales and Marketing Merck & Co, Victrelis, boceprevir, hepatitis C
The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
